MNBTD
ALXN

Moody National Bank Trust Division’s Alexion Pharmaceuticals ALXN Stock Holding History

Moody National Bank Trust Division’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30,472
Closed -$4.66M – 411
2021
Q1 		$4.66M Sell
30,472
-930
-3% -$144K 0.11% 177
2020
Q4 		$4.91M Buy
31,402
+400
+1% +$51.4K 0.13% 149
2020
Q3 		$3.55M Buy
31,002
+25
+0.1% +$2.7K 0.11% 162
2020
Q2 		$3.48M Buy
30,977
+116
+0.4% +$12.3K 0.11% 154
2020
Q1 		$2.77M Buy
30,861
+246
+0.8% +$24.1K 0.1% 150
2019
Q4 		$3.31M Sell
30,615
-45
-0.1% -$4.81K 0.09% 158
2019
Q3 		$3M Sell
30,660
-186
-0.6% -$21K 0.08% 165
2019
Q2 		$4.04M Buy
30,846
+20
+0.1% +$2.58K 0.11% 143
2019
Q1 		$4.17M Buy
30,826
+32
+0.1% +$3.98K 0.11% 141
2018
Q4 		$3M Buy
30,794
+169
+0.6% +$20K 0.09% 154
2018
Q3 		$4.26M Buy
30,625
+27,420
+856% +$3.44M 0.11% 145
2018
Q2 		$397K Hold
3,205
– – 0.02% 183
2018
Q1 		$357K Sell
3,205
-75
-2% -$8.96K 0.02% 192
2017
Q4 		$392K Buy
+3,280
New +$399K 0.02% 186

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Moody National Bank Trust Division's ALXN Position: Q2 2021 in Review

Moody National Bank Trust Division sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 30,472 shares — an estimated $4.66M sold.

Moody National Bank Trust Division first reported a position in ALXN in Q4 2017 and held it in 14 quarters. The position peaked at $4.91M in Q4 2020. 708 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Moody National Bank Trust Division reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Moody National Bank Trust Division sold 30,472 Alexion Pharmaceuticals shares in Q2 2021, an estimated $4.66M.
  • Moody National Bank Trust Division first reported a position in Alexion Pharmaceuticals in Q4 2017 and held it in 14 quarters.
  • Moody National Bank Trust Division's Alexion Pharmaceuticals position peaked at $4.91M in Q4 2020.
  • 708 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Moody National Bank Trust Division's 13F filing for Q2 2021, filed 13 Jul 2021.